Literature DB >> 24583715

Phenotypes of Th lineages generated by the commonly used activation with anti-CD3/CD28 antibodies differ from those generated by the physiological activation with the specific antigen.

Cuiyan Tan1, Lai Wei1, Barbara P Vistica1, Guangpu Shi1, Eric F Wawrousek2, Igal Gery1.   

Abstract

T-helper (Th) lineages have been generated in vitro by activating CD4 cells with anti-CD3/CD28 antibodies during polarization. Physiologically, however, the generation of Th lineages is by activation with the specific antigen presented by antigen-presenting cells (APC). Here, we used T-cell receptor (TCR)-transgenic mice to compare the phenotypes of Th1, Th9 and Th17 lineages when generated by either one of the two activation modes. Lineage Th cells specific against hen egg lysozyme (HEL), were adoptively transferred into recipient mice transgenically expressing HEL in their lens. Remarkable differences were found between lineages of Th1, Th9 or Th17, generated by either one of the two modes in their capacities to migrate to and proliferate in the recipient spleen and, importantly, to induce inflammation in the recipient mouse eyes. Substantial differences were also observed between the lineage pairs in their transcript expression profiles of certain chemokines and chemokine receptors. Surprisingly, however, close similarities were observed between the transcript expression profiles of lineages of the three phenotypes, activated by the same mode. Furthermore, Th cell lineages generated by the two activation modes differed considerably in their pattern of gene expression, as monitored by microarray analysis, but exhibited commonality with lineages of other phenotypes generated by the same activation mode. This study thus shows that (i) Th lineages generated by activation with anti-CD3/CD28 antibodies differ from lineages generated by antigen/APC; and (ii) the mode of activation determines to a large extent the expression profile of major transcripts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24583715      PMCID: PMC4011984          DOI: 10.1038/cmi.2014.8

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  25 in total

1.  Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells.

Authors:  Todd S Davidson; Richard J DiPaolo; John Andersson; Ethan M Shevach
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

2.  Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells.

Authors:  Guangpu Shi; Catherine A Cox; Barbara P Vistica; Cuiyan Tan; Eric F Wawrousek; Igal Gery
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

3.  Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo.

Authors:  Jeremy D Heidel; Joanna Yi-Ching Liu; Yun Yen; Bingsen Zhou; Bret S E Heale; John J Rossi; Derek W Bartlett; Mark E Davis
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

4.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

Review 5.  Heterogeneity and plasticity of T helper cells.

Authors:  Jinfang Zhu; William E Paul
Journal:  Cell Res       Date:  2009-12-15       Impact factor: 25.617

6.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Authors:  Stefanie Eyerich; Kilian Eyerich; Davide Pennino; Teresa Carbone; Francesca Nasorri; Sabatino Pallotta; Francesca Cianfarani; Teresa Odorisio; Claudia Traidl-Hoffmann; Heidrun Behrendt; Stephen R Durham; Carsten B Schmidt-Weber; Andrea Cavani
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

7.  Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.

Authors:  Anneli Jäger; Valérie Dardalhon; Raymond A Sobel; Estelle Bettelli; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

8.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

9.  Immunotolerance against a foreign antigen transgenically expressed in the lens.

Authors:  J C Lai; A Fukushima; E F Wawrousek; M C Lobanoff; P Charukamnoetkanok; S J Smith-Gill; B P Vistica; R S Lee; C E Egwuagu; S M Whitcup; I Gery
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-10       Impact factor: 4.799

10.  Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease.

Authors:  J J Lafaille; F V Keere; A L Hsu; J L Baron; W Haas; C S Raine; S Tonegawa
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

View more
  8 in total

Review 1.  IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Authors:  Junhui Li; Shuqiu Chen; Xiang Xiao; Yong Zhao; Wenjun Ding; Xian C Li
Journal:  Cytokine Growth Factor Rev       Date:  2017-07-17       Impact factor: 7.638

Review 2.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

3.  Shedding New Light on the Process of "Licensing" for Pathogenicity by Th Lymphocytes.

Authors:  Cuiyan Tan; Wambui S Wandu; R Steven Lee; Samuel H Hinshaw; Dennis M Klinman; Eric Wawrousek; Igal Gery
Journal:  J Immunol       Date:  2016-12-16       Impact factor: 5.422

4.  Th2 cells as an intermediate for the differentiation of naïve T cells into Th9 cells, associated with the Smad3/Smad4 and IRF4 pathway.

Authors:  Mohamed Hamed Abdelaziz; Huixuan Wang; Jianjun Cheng; Huaxi Xu
Journal:  Exp Ther Med       Date:  2020-01-03       Impact factor: 2.447

5.  Human Vδ2 T cells are a major source of interleukin-9.

Authors:  Christian Peters; Robert Häsler; Daniela Wesch; Dieter Kabelitz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

6.  Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells.

Authors:  Karmel A Allison; Eniko Sajti; Jana G Collier; David Gosselin; Ty Dale Troutman; Erica L Stone; Stephen M Hedrick; Christopher K Glass
Journal:  Elife       Date:  2016-07-04       Impact factor: 8.140

7.  Immunomodulatory Effects of Taiwanese Neolitsea Species on Th1 and Th2 Functionality.

Authors:  Yin-Hua Cheng; Ying-Chi Lin; Ih-Sheng Chen; Sian-De Liu; Jih-Heng Li; Chia-Chi Wang
Journal:  J Immunol Res       Date:  2017-07-11       Impact factor: 4.818

8.  Pathogen size alters C-type lectin receptor signaling in dendritic cells to influence CD4 Th9 cell differentiation.

Authors:  Seeun Oh; Kai Li; Alexander Prince; Matthew L Wheeler; Hussein Hamade; Christopher Nguyen; Kathrin S Michelsen; David M Underhill
Journal:  Cell Rep       Date:  2022-03-29       Impact factor: 9.995

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.